Clinical Trial to Monitor the Efficacy of the Elosan Treatment by Applying Electrostatic
Prospective, Multi-center, Clinical Trial (Phase IV Study) to Monitor the Efficacy of Treatment by Applying a High Electrostatic Charge to Patients With Chronic Pain, in the Practice of Clinical or Out-patient Pain Treatment Facilities.
1 other identifier
observational
192
1 country
8
Brief Summary
The Treatment Cabin 'Elosan cabin' is a closed, electrically insulated cabin for the short-term application of a high electrostatic voltage to the body of patients with chronic pain. Patients assigned will have 8 sessions in the treatment cabin, with an interval of 6 days between sessions. The existing therapies and painkillers will be continued at the discretion of the doctor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2021
CompletedFirst Submitted
Initial submission to the registry
March 19, 2021
CompletedFirst Posted
Study publicly available on registry
March 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedJanuary 26, 2023
January 1, 2023
1.2 years
March 19, 2021
January 25, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change of Pain Intensity is being assessed by Visual Analogue Scale (VAS)
Change of Pain Intensity is being assessed on a horizontal 100 mm VAS (Visual Analogue Scale) pain scale. The total range of this scale is 100 mm. Minimum score is 0 mm, Maximum score is 100 mm. The higher values represent a higher intensity of pain. The values at baseline will be compared to the values at Visit 8 and the mean of the differences will be compared between the 2 treatment arms.
8-9 weeks
Secondary Outcomes (2)
Composite outcome physical health (PCS) and mental health (MCS) to determine the quality of life assessed by the SF-12 Questionnaire
8-9 weeks
Pain medication / therapy and any changes thereof shall be recorded during the study.
8-9 weeks
Other Outcomes (1)
Improving the quality of sleep
8-9 weeks
Interventions
Study Type is Observational as participants in the study receive therapeutic interventions in the therapy cabin as part of routine medical care and a researcher studies the effect of the intervention. The study includes all persons who are already receiving therapy in the mentioned facilities, no external, specifically selected persons, but existing patients suffering from chronic pain who meet the specified conditions. The therapy aims to alleviate chronic pain by applying an electrostatic charge of 50'000 Volt to the whole body in the special, electrically insulated cabin. The treatment is done upon the instructions of a physician. It is done with the patient standing up in the treatment cabin. The person is charged and discharged several times over the course of 2x 4 minutes. The charge can be felt on the skin and it can be seen through bristling of the hairs on the body. This treatment is repeated once a week.
Eligibility Criteria
The study will include pain patients who are already being treated in the practice of clinical or resident pain therapy facilities.
You may qualify if:
- Informed Consent
- adults, age ≥ 18 years, male or female patients
- History of pain ≥ 3 months
- Suffering from chronic pain
- Intensity of pain rated ≥ 50 mm on VAS pain
You may not qualify if:
- Patients with an electrical or electronic implant.
- Women who are pregnant, breastfeeding or planning to become pregnant
- Patients who have already been treated with the cabin within the last 4 weeks.
- Patients who are currently participating in other studies or who have participated in other studies in the last 30 days
- Patients who have indicated their intention or who are suspected of intending to discontinue or discontinue therapy before the end of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Elosan AGlead
Study Sites (8)
Centro Ortho-Bio-Med
Roveredo, CH, 6535, Switzerland
Zentrum für Neurochirurgie Hirslanden Ostschweiz
Sankt Gallen, CH, 9016, Switzerland
Medizinisches Zentrum
Bad Ragaz, 7310, Switzerland
Spital Emmental, Schmerzzentrum
Burgdorf, 3400, Switzerland
Rheumapraxis Cham Zug
Cham, 6330, Switzerland
Praxis Dr. Kessler
Lucerne, 6006, Switzerland
Orthopädische Schmerztherapie Zürich
Zurich, 8003, Switzerland
Schulthess Klinik Zürich
Zurich, 8063, Switzerland
Related Publications (1)
Steinhauser S, Ganter MT, Stadelmann V, Hofer CK; ELES Study Group. Whole-Body Electrostatic Pain Treatment in Adults with Chronic Pain: A Prospective Multicentric Observational Clinical Trial. Pain Ther. 2024 Feb;13(1):69-85. doi: 10.1007/s40122-023-00560-8. Epub 2023 Nov 28.
PMID: 38015366DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan Steinhauser, M.D.
Stadtspital Triemli, 8063 Zürich
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2021
First Posted
March 26, 2021
Study Start
March 16, 2021
Primary Completion
May 15, 2022
Study Completion
June 15, 2022
Last Updated
January 26, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share